Discover the future of computing and nanotechnology this summer. Learn how DNA, RNA, and proteins can be engineered to sense, ...

A high-fat diet forces liver cells to adapt for survival rather than function, creating metabolic stress that affects ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

From exhibitions on the experiences of motherhood to global precarity, and even one show that delves inside the minds of our ...

To begin to close the equity gap in diabetes, we must commit to designing therapies that account for the practical realities ...

The U.S. Food and Drug Administration (FDA) have granted approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj), ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

In 2001, chemists K. Barry Sharpless, Hartmuth C. Kolb, and M. G. Finn introduced click chemistry, a concept in which organic molecules can be rapidly and reliably joined to form more complex ...

Nerve fibers in the brain and spinal cord are wrapped in an insulating sheath known as myelin. For a long time, this barrier, which is essentially the brain's white matter, was believed to serve the ...

Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

Detailed price information for Telo Genomics Corp (TELO-X) from The Globe and Mail including charting and trades.